These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 8232233)

  • 1. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE; Breivogel CS; Childers SR
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
    Chang KJ; Rigdon GC; Howard JL; McNutt RW
    J Pharmacol Exp Ther; 1993 Nov; 267(2):852-7. PubMed ID: 8246159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
    Costa T; Klinz FJ; Vachon L; Herz A
    Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
    J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    Prather PL; Loh HH; Law PY
    Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC; Maullu C; Onali P
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase activity in rat olfactory bulb.
    Olianas MC; Onali P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1560-7. PubMed ID: 8531129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand.
    Campa MJ; Schreiber G; Bepler G; Bishop MJ; McNutt RW; Chang KJ; Patz EF
    Cancer Res; 1996 Apr; 56(7):1695-701. PubMed ID: 8603422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    Werling LL; Puttfarcken PS; Cox BM
    Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG; Traynor JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin-selective inhibition of adenylyl cyclase in guinea pig cerebellum membranes.
    Konkoy CS; Childers SR
    Mol Pharmacol; 1989 Oct; 36(4):627-33. PubMed ID: 2572962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist Activity of the delta-antagonists TIPP and TIPP-psi in cellular models expressing endogenous or transfected delta-opioid receptors.
    Martin NA; Terruso MT; Prather PL
    J Pharmacol Exp Ther; 2001 Jul; 298(1):240-8. PubMed ID: 11408548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.
    Selley DE; Bidlack JM
    J Pharmacol Exp Ther; 1992 Oct; 263(1):99-104. PubMed ID: 1328614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.